Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)
China · Delayed Price · Currency is CNY 13.52
+0.02 (0.15%)
Feb 3, 2026, 3:04 PM CST
SHE:002675 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 166.07 | 183.83 | 209.74 | 307.29 | 151.56 | 417.77 |
Depreciation & Amortization | 160.69 | 160.69 | 147.25 | 125.09 | 114.93 | 102.74 |
Other Amortization | 13.78 | 13.78 | 6.2 | 5.35 | 4.53 | 3.4 |
Loss (Gain) From Sale of Assets | -0.3 | -0.3 | -0.06 | -0.13 | 0.15 | 1.29 |
Asset Writedown & Restructuring Costs | 85.9 | 85.9 | -1.33 | 80.62 | 211.42 | 0.32 |
Loss (Gain) From Sale of Investments | 12.92 | 12.92 | 8.54 | 39.21 | 12.15 | -9.77 |
Provision & Write-off of Bad Debts | 16.44 | 16.44 | -5.19 | 2.56 | 1.47 | 8.92 |
Other Operating Activities | 210.82 | 37.02 | 216.15 | 69.69 | 152.95 | 125.2 |
Change in Accounts Receivable | -124.86 | -124.86 | 174.75 | -23.63 | 129.89 | -20.06 |
Change in Inventory | 261.39 | 261.39 | 66.11 | -112.36 | 10.51 | -94.72 |
Change in Accounts Payable | -447.96 | -447.96 | -524.11 | 330.58 | 176.68 | 32.14 |
Change in Other Net Operating Assets | 95.84 | 95.84 | 3.67 | 175.61 | -16.74 | 5.11 |
Operating Cash Flow | 443.2 | 287.15 | 276.94 | 996.54 | 943.58 | 572.58 |
Operating Cash Flow Growth | 22.41% | 3.69% | -72.21% | 5.61% | 64.80% | -17.78% |
Capital Expenditures | -285.18 | -456.09 | -511.95 | -389.61 | -530.16 | -262.19 |
Sale of Property, Plant & Equipment | 9.12 | 0.72 | 1.08 | 0.45 | 0.29 | 13.61 |
Cash Acquisitions | - | -3.46 | -202.19 | 0.03 | - | -99.11 |
Investment in Securities | -109.73 | -264.04 | 78.15 | -72.51 | -214.78 | -193.88 |
Other Investing Activities | 15.06 | 7.88 | 32.1 | 8.89 | 5.41 | 10.84 |
Investing Cash Flow | -389.19 | -715 | -602.8 | -452.75 | -739.25 | -530.72 |
Short-Term Debt Issued | - | 8.91 | - | - | - | - |
Long-Term Debt Issued | - | 878.18 | 558.36 | 526.68 | 588.55 | 1,823 |
Total Debt Issued | 632.31 | 887.09 | 558.36 | 526.68 | 588.55 | 1,823 |
Short-Term Debt Repaid | - | -4.11 | -7 | -8.06 | - | - |
Long-Term Debt Repaid | - | -811.75 | -460.2 | -912.74 | -540.03 | -1,634 |
Total Debt Repaid | -784.82 | -815.86 | -467.2 | -920.8 | -540.03 | -1,634 |
Net Debt Issued (Repaid) | -152.51 | 71.23 | 91.16 | -394.12 | 48.52 | 189.01 |
Issuance of Common Stock | 426.16 | 689.6 | 166.5 | 286.24 | 65.28 | 17.1 |
Common Dividends Paid | -148.27 | -217.25 | -258.33 | -251.24 | -302.48 | -347.61 |
Other Financing Activities | 16.29 | - | - | - | - | 0.01 |
Financing Cash Flow | 141.68 | 543.58 | -0.68 | -359.13 | -188.68 | -141.49 |
Foreign Exchange Rate Adjustments | 7.24 | 12.15 | 7.42 | 6.26 | 6.75 | -3.32 |
Net Cash Flow | 202.93 | 127.88 | -319.11 | 190.93 | 22.4 | -102.95 |
Free Cash Flow | 158.02 | -168.94 | -235 | 606.93 | 413.42 | 310.39 |
Free Cash Flow Growth | - | - | - | 46.80% | 33.20% | -30.45% |
Free Cash Flow Margin | 5.75% | -5.89% | -7.17% | 16.94% | 10.57% | 9.08% |
Free Cash Flow Per Share | 0.19 | -0.20 | -0.28 | 0.75 | 0.52 | 0.39 |
Cash Income Tax Paid | 182.42 | 146.99 | 145.68 | -4.72 | 41.63 | 122.98 |
Levered Free Cash Flow | 103.68 | -235.75 | -358.67 | 282.45 | 181.52 | -7.98 |
Unlevered Free Cash Flow | 180.19 | -175.43 | -323.2 | 319.1 | 216.8 | 21.89 |
Change in Working Capital | -223.12 | -223.12 | -304.33 | 366.86 | 294.42 | -77.29 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.